Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96134802 | 9613480 | 2 | F | 20160803 | 20131010 | 20160804 | EXP | VE-ROCHE-1286981 | ROCHE | 0.00 | F | Y | 61.00000 | KG | 20160804 | CN | VE | VE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96134802 | 9613480 | 1 | PS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Subcutaneous | LAST DOSE PEGINTERFERON ON 02-OCT-2013 | U | 103964 | 180 | UG | /wk | ||||||
| 96134802 | 9613480 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | U | 21511 | 800 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96134802 | 9613480 | 1 | Hepatitis C |
| 96134802 | 9613480 | 2 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96134802 | 9613480 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96134802 | 9613480 | Choluria | |
| 96134802 | 9613480 | Diarrhoea | |
| 96134802 | 9613480 | Epistaxis | |
| 96134802 | 9613480 | Gingival bleeding | |
| 96134802 | 9613480 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 96134802 | 9613480 | 1 | 20130919 | 0 | ||
| 96134802 | 9613480 | 2 | 20130919 | 0 |